Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation
- PMID: 34407544
- PMCID: PMC8703366
- DOI: 10.1182/blood.2021011525
Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation
Abstract
Multiple organ dysfunction is the most severe outcome of sepsis progression and is highly correlated with a worse prognosis. Excessive neutrophil extracellular traps (NETs) are critical players in the development of organ failure during sepsis. Therefore, interventions targeting NET release would likely effectively prevent NET-based organ injury associated with this disease. Herein, we demonstrate that the pore-forming protein gasdermin D (GSDMD) is active in neutrophils from septic humans and mice and plays a crucial role in NET release. Inhibition of GSDMD with disulfiram or genic deletion abrogated NET formation, reducing multiple organ dysfunction and sepsis lethality. Mechanistically, we demonstrate that during sepsis, activation of the caspase-11/GSDMD pathway controls NET release by neutrophils during sepsis. In summary, our findings uncover a novel therapeutic use for disulfiram and suggest that GSDMD is a therapeutic target to improve sepsis treatment.
© 2021 by The American Society of Hematology.
Figures
Comment in
-
Old drug revisited: disulfiram, NETs, and sepsis.Blood. 2021 Dec 23;138(25):2604-2605. doi: 10.1182/blood.2021013438. Blood. 2021. PMID: 34940816 No abstract available.
References
-
- Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006;368(9530):157-169. - PubMed
-
- Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159-175. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
